USD
+$0.00
(+0.00%
)At Close (As of Oct 14, 2025)
$10.16B
Market Cap
68.91
P/E Ratio
3.78
EPS
$310.00
52 Week High
$198.68
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $755M |
Total Revenue | $1.2B |
Cost Of Revenue | $440M |
Costof Goods And Services Sold | $440M |
Operating Income | $9.3M |
Selling General And Administrative | $574M |
Research And Development | $95M |
Operating Expenses | $746M |
Investment Income Net | - |
Net Interest Income | $12M |
Interest Income | $14M |
Interest Expense | $1.4M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $24M |
Income Before Tax | $21M |
Income Tax Expense | $6.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $14M |
Comprehensive Income Net Of Tax | - |
Ebit | $22M |
Ebitda | $46M |
Net Income | $14M |
Field | Value (USD) |
---|---|
Total Assets | $1.5B |
Total Current Assets | $951M |
Cash And Cash Equivalents At Carrying Value | $324M |
Cash And Short Term Investments | $324M |
Inventory | $407M |
Current Net Receivables | $168M |
Total Non Current Assets | $582M |
Property Plant Equipment | $268M |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $6.5M |
Intangible Assets Excluding Goodwill | $6.5M |
Goodwill | $166M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $16M |
Other Current Assets | $37M |
Other Non Current Assets | - |
Total Liabilities | $382M |
Total Current Liabilities | $158M |
Current Accounts Payable | $31M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $15M |
Total Non Current Liabilities | $224M |
Capital Lease Obligations | $223M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $223M |
Other Current Liabilities | $112M |
Other Non Current Liabilities | $15M |
Total Shareholder Equity | $1.2B |
Treasury Stock | - |
Retained Earnings | $60M |
Common Stock | $38K |
Common Stock Shares Outstanding | $39M |
Field | Value (USD) |
---|---|
Operating Cashflow | $168M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $24M |
Capital Expenditures | $21M |
Change In Receivables | - |
Change In Inventory | -$66M |
Profit Loss | - |
Cashflow From Investment | $78M |
Cashflow From Financing | -$87M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$100M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $14M |
Field | Value (USD) |
---|---|
Gross Profit | $755M |
Total Revenue | $1.2B |
Cost Of Revenue | $440M |
Costof Goods And Services Sold | $440M |
Operating Income | $9.3M |
Selling General And Administrative | $574M |
Research And Development | $95M |
Operating Expenses | $746M |
Investment Income Net | - |
Net Interest Income | $12M |
Interest Income | $14M |
Interest Expense | $1.4M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $24M |
Income Before Tax | $21M |
Income Tax Expense | $6.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $14M |
Comprehensive Income Net Of Tax | - |
Ebit | $22M |
Ebitda | $46M |
Net Income | $14M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Penumbra, Inc. is a leading medical device company that specializes in designing, developing, and manufacturing innovative products aimed at treating neurological and vascular conditions. Headquartered in Alameda, California, the company operates globally, with a presence in key markets such as the United States, Europe, Canada, and Australia. Penumbra's commitment to advancing healthcare through cutting-edge technology positions it as a critical player in the medical device industry, focusing on enhancing patient outcomes and clinician experience.